Connect with us

Health Care

Cybin CEO Participation in Upcoming Events Recognizes Company Expertise

Published

on

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
CEO to participate in panel discussion, fireside chat focusing on psychedelics,
The company is engineering next-generation psychedelic molecules as it works to transform the mental health treatment landscape
CYBN is implementing a three-pillar strategy

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is gaining recognition as a leader in the psychedelic space. Evidence of this can be seen in the Cybin CEO’s upcoming participation in two virtual investor conferences (https://ibn.fm/1zAF4).

The company announced that CEO Doug Drysdale has been invited to participate in a panel discussion titled “Psychedelics: More Than Just a Trip” during the…

Read More>>

NOTE TO INVESTORS: The latest …

Full story available on Benzinga.com

Article: benzinga.com

Health Care

6,500-acre Forest in Central Vermont Protected for Conservation

Published

on

6,500-acre forest in central Vermont protected for conservation WCAX

Source Here: wcax.com

Continue Reading

Health Care

Vermont Story Lab Announces Winter Labs Offered Online

Published

on

Vermont Story Lab announces winter labs offered online Vermont Biz

Original Article: vermontbiz.com

Continue Reading

Health Care

Rep. Lori Trahan, Sen. Bernie Sanders Reintroduce Masks for All Act to Get Americans N95 Masks

Published

on

Rep. Lori Trahan, Sen. Bernie Sanders reintroduce Masks for All Act to get Americans N95 masks MassLive.com

Source Here: masslive.com

Continue Reading

Trending

ConnectingWire.com